Featured Research

from universities, journals, and other organizations

UCSF Researchers Identify Molecule Involved In Early Stage Of Atherosclerosis In Mice

Date:
August 28, 1998
Source:
University Of California, San Francisco
Summary:
UC San Francisco researchers have demonstrated in genetically engineered mice that a molecule known as MCP-1 plays a key role in promoting the migration of white blood cells into the lining of arteries, an event that ultimately leads to atherosclerosis.

UC San Francisco researchers have demonstrated in genetically engineered mice that a molecule known as MCP-1 plays a key role in promoting the migration of white blood cells into the lining of arteries, an event that ultimately leads to atherosclerosis.

The finding, reported in the August 27 issue of Nature, provides evidence that MCP-1 is critically involved in the formation of foam cell-laden fatty streaks, a hallmark of atherosclerosis, according to the senior author of the study, Israel F. Charo, MD, PhD, associate director of the UCSF-affiliated Gladstone Institute of Cardiovascular Disease, and a professor of medicine at UCSF.

"We've identified a mechanism whereby oxidized lipids attract monocytes to the vessel wall," said Charo.

"This should encourage pharmaceutical companies to ramp up their efforts to find an antagonist for this receptor."

Researchers have long known that the movement of monocytes, a type of white blood cell, into artery walls is an early step in the development of atherosclerosis. And cell culture studies have provided strong evidence that MCP-1 (monocyte chemoattractant protein-1) is a powerful attractant for monocytes. Significantly, synthesis of MCP-1 in blood vessel wall cells, such as endothelial cells, is upregulated by oxidized lipids.

The Gladstone researchers set out to determine whether MCP-1 was, in fact, the molecular lynch pin between the oxidized lipids resulting from a high-fat diet and the migration of monocytes into the artery wall.

Charo's team examined the outcomes in two sets of mice that were genetically engineered to be highly susceptible to atherosclerosis. One group of mice was also missing the receptor (CCR2) for MCP-1 on monoctyes that allows MCP-1 to have an effect. Both groups of mice were fed a western-type, high-fat diet for five to 13 weeks and then analyzed for signs of atherosclerosis.

The results were dramatic. The first group of mice developed robust lesions on their proximal aortas. In contrast, mice lacking CCR2 had lesions that were nearly 50 percent smaller. In addition, markedly fewer macrophages, the cells that monocytes evolve into once they are in the vessel lining, were present in the aortas of these mice, demonstrating that activation of the receptor was important in the recruitment of monocytes into the vessel wall.

Co-authors of the UCSF study were Landin Boring, PhD, a postdoctoral fellow in the UCSF-affiliated Gladstone Institute of Cardiovascular Disease, Jennifa Gosling, MS, a research associate at the Gladstone and Michael Cleary, a research associate at the Gladstone. The study was funded by grants from the NIH and Gladstone Institute of Cardiovascular Disease.


Story Source:

The above story is based on materials provided by University Of California, San Francisco. Note: Materials may be edited for content and length.


Cite This Page:

University Of California, San Francisco. "UCSF Researchers Identify Molecule Involved In Early Stage Of Atherosclerosis In Mice." ScienceDaily. ScienceDaily, 28 August 1998. <www.sciencedaily.com/releases/1998/08/980828072835.htm>.
University Of California, San Francisco. (1998, August 28). UCSF Researchers Identify Molecule Involved In Early Stage Of Atherosclerosis In Mice. ScienceDaily. Retrieved September 23, 2014 from www.sciencedaily.com/releases/1998/08/980828072835.htm
University Of California, San Francisco. "UCSF Researchers Identify Molecule Involved In Early Stage Of Atherosclerosis In Mice." ScienceDaily. www.sciencedaily.com/releases/1998/08/980828072835.htm (accessed September 23, 2014).

Share This



More Health & Medicine News

Tuesday, September 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Costs Keep Mounting

Ebola Costs Keep Mounting

Reuters - Business Video Online (Sep. 23, 2014) The WHO has warned up to 20,000 people could be infected with Ebola over the next few weeks. As Sonia Legg reports, the implications for the West African countries suffering from the disease are huge. Video provided by Reuters
Powered by NewsLook.com
WHO: Ebola Cases to Triple in Weeks Without Drastic Action

WHO: Ebola Cases to Triple in Weeks Without Drastic Action

AFP (Sep. 23, 2014) The number of Ebola infections will triple to 20,000 by November, soaring by thousands every week if efforts to stop the outbreak are not stepped up radically, the WHO warned in a study on Tuesday. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
5 Ways Men Can Prevent Most Heart Attacks

5 Ways Men Can Prevent Most Heart Attacks

Newsy (Sep. 23, 2014) No surprise here: A recent study says men can reduce their risk of heart attack by maintaining a healthy lifestyle, which includes daily exercise. Video provided by Newsy
Powered by NewsLook.com
Liberia Pleads for Help to Fight Ebola

Liberia Pleads for Help to Fight Ebola

AP (Sep. 22, 2014) Liberia's finance minister is urging the international community to quickly follow through on pledges of cash to battle Ebola. Bodies are piling up in the capital Monrovia as the nation awaits more help. (Sept. 22) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins